Floy
Munich
About Floy
Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases. One of Floy’s distinguishing features is our innovative incentive structure. We partner with radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption. Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $13.3M
- Funding stage: Seed
- Last round: Seed (Feb 2025)
- Website: floy.com
- Phone: +4989244136090
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, SaaS, Software
Social Profiles
Canonical: https://fsome.com/organization/floy-67726 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.